BACKGROUND: The Precision((R)) (Abbott Diabetes Care) point-of-care biosensor test strips are widely used by patients with diabetes and clinical laboratories for measurement of plasma beta-hydroxybutyrate (beta-HB) concentrations in capillary blood samples obtained by fingerstick. In the literature, this procedure has been validated only against the enzymatic determination of beta-HB in venous plasma, i.e., the method to which the Precision((R)) has been calibrated. METHODS: In this study, the Precision((R)) Xceed was compared to a methodologically different and superior procedure: determination of beta-HB by liquid chromatography tandem-mass spectrometry (LC-MS/MS) in capillary blood spots. Blood spots were obtained from the same fingerstick sample from out of which Precision((R)) measurements were performed. Linearity was tested by adding varying amounts of standard to an EDTA venous whole blood matrix. RESULTS: The Precision((R)) was in good agreement with LC-MS/MS within the measuring range of 0.0-6.0 mmol/L (Passing and Bablok regression: slope=1.20 and no significant intercept, R=0.97, n=59). Surprisingly, the Precision((R)) showed non-linearity and full saturation at concentrations above 6.0 mmol/L, which were confirmed by a standard addition experiment. Results obtained at the saturation level varied between 3.0 and 6.5 mmol/L. CONCLUSIONS: The Precision((R)) beta-HB test strips demonstrate good comparison with LC-MS/MS. Inter-individual variation around the saturation level, however, is large. Therefore, we advise reporting readings above 3.0 as >3.0 mmol/L. The test is valid for use in the clinically relevant range of 0.0-3.0 mmol/L.